Vertex’s executive chairman: Here’s how we got our drug-trial success rate over 70% when the industry’s is 10% to 20%

More bets don’t necessarily produce more successes
This is a brief. The reporting belongs to Fortune — read the complete story, with full context and credits, at the source.
Read the full story at Fortune ↗fortune.com
More from the Business desk
Just in

Centrica boss 'hugely concerned' over impact of soaring energy bills

Zohran Mamdani on Trump, Wall Street and Wealth Taxes
Can stocks bounce back after a brutal week? This timing model says history is on the market’s side.
